Pay in 4 interest-free payments of $5.61 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Those initiating statin monotherapy were matched 1:1 using propensity scores with patients starting combination therapy with a lower-potency statin and ezetimibe
To take these time-dependent changes in GSH into consideration, the area under the GSH content versus time curve (AUC), with and without ADR treatment, was calculated for each cell line
Patience during this period is essential
For systemic benefits, oral supplements are more reliable
All authors were involved in revisions
US$ 20.67
US$ 28.75
US$ 23.32
US$ 21.10
US$ 23.18
US$ 22.98
US$ 28.77
